Kalvista Pharmaceuticals, Inc. (KALV)

Last Three Months

29-Dec-23 -- 28-Mar-24

Time Period:
  • Three Months
  •  | 
  • Year

$6.67M Net Amount
Buy:$7.19M$12.11 - $14.22
Sell:($520.81K)$13.00 - $13.03

Company Sentiment

Drugs - Generic

Drugs

Insider Trading Sentiment: Hold
Insider Trading Sentiment: Hold
Insider Trading Sentiment: Hold
Sentiment Breakdown by Insider
1
(3)
0
(2)
0
(1)
12
0
4
+1
0
+2
1
+3

Two Year Chart

29-Mar-22 -- 28-Mar-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades

Last TransactionLast Three Months
SEC FilingTransactionInsiderSentimentCompanyHoldings ChangeBuy AmountSell AmountBuy Price RangeSell Price Range
21-Feb-24 9:48 PM
View: 
20-Feb-24
Option Sale
($170.12K)
Yea Christopher
Chief Development Officer
Insider Trading Sentiment for Yea Christopher at Kalvista Pharmaceuticals, Inc. (KALV):Kalvista Pharmaceuticals, Inc. - KALV58%
46.05K to 72.89K
0
0
---- Show TxnsShow Insider Trades
21-Feb-24 9:51 PM
View: 
20-Feb-24
Sale (Planned)
($133.45K)
Feener Edward P.
Chief Scientific Officer
Insider Trading Sentiment for Feener Edward P. at Kalvista Pharmaceuticals, Inc. (KALV):Kalvista Pharmaceuticals, Inc. - KALV(22%)
79.83K to 62.16K
0
($520.81K)
(50%)
--$13.00 - $13.03 Show TxnsShow Insider Trades
21-Feb-24 9:41 PM
View: 
20-Feb-24
Option Sale
($351.29K)
Insider Trading Sentiment for Crockett Thomas Andrew at Kalvista Pharmaceuticals, Inc. (KALV):Kalvista Pharmaceuticals, Inc. - KALV66%
127.53K to 211.2K
0
0
---- Show TxnsShow Insider Trades
21-Feb-24 9:44 PM
View: 
20-Feb-24
Option Sale
($201.77K)
Audhya Paul K.
Chief Medical Officer
Insider Trading Sentiment for Audhya Paul K. at Kalvista Pharmaceuticals, Inc. (KALV):Kalvista Pharmaceuticals, Inc. - KALV45%
36.57K to 52.89K
0
0
---- Show TxnsShow Insider Trades
08-Feb-24 8:11 PM
View: 
08-Feb-24
Purchase
$437.28K
Insider Trading Sentiment for Venrock Healthcare Capital Partners Iii, L.P. at Kalvista Pharmaceuticals, Inc. (KALV):Kalvista Pharmaceuticals, Inc. - KALV18%
4.09M to 4.82M
$7.19M
14%
0
$12.11 - $14.22-- Show TxnsShow Insider Trades
21-Feb-24 9:46 PM
View: 
20-Feb-24
Option Sale
($321.85K)
Palleiko Ben
CHIEF EXECUTIVE OFFICER
Director
Insider Trading Sentiment for Palleiko Ben at Kalvista Pharmaceuticals, Inc. (KALV):Kalvista Pharmaceuticals, Inc. - KALV67%
112.44K to 187.31K
0
0
---- Show TxnsShow Insider Trades